Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Capital Expenditures (2019 - 2025)

Outset Medical (OM) has disclosed Capital Expenditures for 7 consecutive years, with $223000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 126.61% to $223000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $798000.0, a 2474.19% increase, with the full-year FY2025 number at $798000.0, up 2474.19% from a year prior.
  • Capital Expenditures was $223000.0 for Q4 2025 at Outset Medical, up from $160000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.9 million in Q4 2021 to a low of -$6.0 million in Q4 2022.
  • A 5-year average of $213150.0 and a median of $265000.0 in 2021 define the central range for Capital Expenditures.
  • Biggest YoY gain for Capital Expenditures was 521.01% in 2022; the steepest drop was 309.31% in 2022.
  • Outset Medical's Capital Expenditures stood at $2.9 million in 2021, then plummeted by 309.31% to -$6.0 million in 2022, then skyrocketed by 63.17% to -$2.2 million in 2023, then skyrocketed by 62.39% to -$838000.0 in 2024, then soared by 126.61% to $223000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Capital Expenditures are $223000.0 (Q4 2025), $160000.0 (Q3 2025), and $292000.0 (Q2 2025).